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Sulnnlary 
Limited regions of amino acid sequence similarity frequently occur between microbial antigens 
and host proteins. It has been widely anticipated that during infection such sequence similarities 
could induce cross-reactive T cell responses, thereby initiating T cell-mediated autoimmune disease. 
However, the nature of major histocompatibility complex (MHC)-restricted antigen presentation 
confers a number of constraints that should make this type of T cell cross-reactivity a rare, MHC 
allele-dependent event. We tested this prediction using two insulin-dependent diabetes mellitus 
(IDDM)-associated antigens, coxsackievirus P2-C (Cox P2-C) protein and glutamate decarboxylase 
(GAD65), which share a prototypic sequence similarity of six consecutive amino acids within 
otherwise unrelated proteins. We surveyed a panel of 10 murine MHC dass II alleles that encompass 
the spectrum of standard alleles for the ability to cross-reactively present Cox P2-C and GAD65. 
Out of the 10 restriction elements tested, the sequence similarity regions were both dominant 
determinants and were cross-reactively displayed after the natural processing of whole antigens, 
only in the context of I-A  n~  These data show that cross-reactive T cell recognition of sequence 
similarity regions in unrelated proteins is confined to certain MHC alleles, which may explain 
MHC association with autoimmune disease. It is striking that these two diabetes-assodated  antigens 
were cross-reactively recognized only in the context of a diabetes susceptibility allele. Since the 
human and the murine dass II alleles associated  with IDDM share conserved features, cross- 
reactive T cell recognition of GAD65 and Cox P2-C may contribute to the pathogenesis of human 
IDDM and account for the epidemiological association of coxsackievirus with IDDM. 
N 
'aive, potentially autoreactive T cells can persist indefi- 
nitely in healthy individuals, "ignorant" of the endog- 
enous autoantigen. However, if these naive T  cells become 
activated and differentiate into effector/memory  cells, autoim- 
mune disease may result (1). Therefore, priming of autoanti- 
gen-specific T cells is critical for the development of autoim- 
munity and it is widely anticipated that microbial antigens 
which cross-react with host proteins are the etiologic agents 
that initiate an autoimmune T  cell response (2). 
Microbial antigens that are candidates for triggering cross- 
reactive T  cell responses fall into two categories. The first 
consists of homologous proteins that are conserved through 
evolution and that are expressed by both the infectious agent 
and the host.  Owing to their overall  sequence homology, 
antigen processing and presentation of the two homologous 
proteins are likely to produce identical or closely related de- 
terminants. The best-studied example in this category is the 
cross-reactive T cell recognition of mycobacterial heat shock 
protein (HSP) and host HSP which can induce experimental 
autoimmune disease (for a review see reference 3). 
The second category of antigens that are candidates for 
1979 
triggering cross-reactive T cell responses are microbial pro- 
teins  that  share  limited  regions  of amino  acid  sequence 
similarity with a nonhomologous host protein. The sequence 
similarity between the 40-kD coxsackievirus P2-C protein 
(Cox P2-C), a protein which is involved in viral replication, 
and the 65-kD  glutamate decarboxylase (GAD65),  a neu- 
rotransmitter synthesizing enzyme expressed in the brain and 
the/3 cells of the pancreas, is prototypic of this category (4). 
Both of these antigens have been associated with the patho- 
genesis of insulin-dependent diabetes mellitus (IDDM). Cox- 
sackievirus has been experimentally and epidemiologically as- 
sociated with IDDM  (4-10)  and T  cell autoimmunity to 
GAD65 has been shown to play a key role in the induction 
and propagation of/3 cell autoimmunity in murine IDDM 
(11, 12) and may also play a role in human IDDM (13). These 
two antigens share a stretch of six consecutive amino acids 
in otherwise unrelated primary amino acid sequences. 
Although small regions of sequence similarity (usually span- 
ning four to six amino acids) are frequently identified by com- 
puter searches of DNA and protein databases,  it remains un- 
clear whether they actually can be cross-reactively recognized 
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Experimental  evidence in support of T  cell cross-reactivity 
between sequence similarities in nonhomologous proteins of 
microbial and host origin is limited to two examples: (a) T 
cells primed by a synthetic peptide of hepatitis B virus poly- 
merase which shares  6 of 10 amino acids with myelin basic 
protein can induce experimental allergic encephalomyelitis  (14). 
However, since the use of a synthetic peptide bypasses the 
antigen-processing compartment, it is unknown whether the 
cross-reaction also occurs after exposure to, and processing 
of, the native antigens. (b) Immunization with yeast histone, 
which contains a stretch of five amino acids that is identical 
to a region in retinal binding protein, can induce uveitis (15). 
The rules for cross-reactive T cell recognition of sequence 
similarity regions in unrelated proteins have not been syste- 
matically studied. Based on our understanding of antigen pro- 
cessing and presentation, T  cell cross-reactivity between se- 
quence similarities in nonhomologous proteins should be a 
rare event that is dependent upon the nonoverlapping amino 
acid sequences of both antigens as well as the MHC haplo- 
type of the host. The unrelated primary sequences of the two 
proteins should lead to unique patterns of cleavage sites for 
proteases.  Therefore,  during  the natural  processing  of the 
whole antigens,  peptides containing  the sequence similari- 
ties may, or may not, be generated from either antigen for 
binding  to MHC (for a review see reference 16).  If gener- 
ated, both peptides encompassing the sequence similarity reo 
gion have to display high affinity for the same MHC product, 
high enough to constitute a dominant determinant (usually, 
only one peptide from a complex protein constitutes a domi- 
nant determinant).  Whereas endogenously generated deter- 
minants are 10-15 amino acids long, the regions of sequence 
similarity are considerably shorter (4-6 amino acids). Conse- 
quently, differences in residues flanking the sequence similarity 
may profoundly affect each peptide's affinity for the MHC 
molecule, the MHC anchor residues employed, and the spa- 
tial orientation of the sequence similarity residues on the MHC 
molecule,  such that  cross-reactivity fails to occur. 
To be recognized by a single TCR when bound to MHC 
molecules, both peptides have to display amino acids of the 
sequence similarity region in identical spatial orientation rel- 
ative to the MHC molecule itself.  Therefore, based on the 
nature of antigen recognition by T  cells,  cross-reactive rec- 
ognition of sequence similarity regions on unrelated proteins 
should be a rare, MHC allele-dependent event. However, this 
prediction, which may be fundamental to the understanding 
of autoimmune disease, has not been experimentally addressed. 
Choosing the coxsackievirus/GAD65 paradigm, we tested 
whether  cross-reactive T  cell recognition  of the  sequence 
similarity regions on these two otherwise unrelated proteins 
would occur, and if it occurred, how frequent permissive MHC 
alleles are. We report that of 10 murine restriction elements 
tested, cross-reactive presentation occurred in the context of 
only one,  the "diabetes susceptibility allele"  I-A  n~ 
free conditions. Bm12, SJL/L, B10.Q, B10.A (4R), C57.BL/6 mice 
were purchased from The Jackson Laboratory (Bar Harbor, ME). 
B10.GD mice were provided by Eli Sercarz (University of California, 
Los Angeles). 
Antigens.  Recombinant human GAD65, Cox P2-C, and Esch- 
erichia coli /3-galactosidase were purified from recombinant E. coli 
on the basis of a histidine tag and metal affinity chromatography 
(11, 17). Peptides were synthesized using standard Fmoc chemistry 
and purified by chromatography.  The peptide  composition  was 
verified by mass spectrometry. The GAD65 sequence similarity pep- 
tide (GAD ssp) is: ARYKMFPEVKEKGMAA.  The Cox P2-C se- 
quence similarity peptide (Cox ssp) is: LKVKILPEVKEKHEFL 
(see Fig. 1). The control hen eggwhite lysozyme peptide (HELl1-25, 
AMKRHGLDNYRGYSL), immunogenic  in  NOD  mice, was 
provided by Eli Sercarz. 
Immunization Protocols.  Male  mice were immunized subcutane- 
ously at the ages indicated with 7 nmol protein (Cox P2-C, GAD65, 
or 3-galactosidase), or peptide (Cox ssp, GAD ssp, or HELu-2s), 
emulsified in CFA (Difco Laboratories Inc., Detroit, MI). 9 d later, 
draining lymph nodes were assayed  for proliferative T cell responses. 
T Cell Proliferation Assays.  Single  cell suspensions of draining 
lymph node cells were cultured at 4  x  105 cells/well in triplicates 
in 96-well microtiter  plates with HD1 serum-free medium (Ven- 
trex Laboratories, Portland,  ME), 2 mM glutamine,  100 U peni- 
cillin, and 100/~g streptomycin per ml. Antigens were present at 
20 I~g/ml for whole proteins and 7/~M for peptides (the optimal 
concentrations  determined  in  our previous  study;  11). Con  A 
(2.5/zg/ml)  or purified protein derivative of mycobacterium tuber- 
culosis (PPD) (5/zg/ml)  was used as a positive control [3H]thymi- 
dine was added during the last 12-18 h of a 5-d culture and incor- 
poration  of label was measured by liquid  scintillation counting. 
Results  and Discussion 
GAD65 and Cox P-2C ssp Induce Cross-reactive T  Cell Re- 
sponses only in NOD Mice.  We synthesized the peptides that 
encompass the sequence similarity region in Cox P2-C and 
GAD65 (Cox ssp and GAD ssp, Fig.  1) and tested whether 
these peptides are  immunogenic  in  the context  of a panel 
of H-2 class II alleles (Table 1). First, we focused on various 
I-E-  mouse strains,  which permitted us to test for I-A-re- 
stricted responses.  Subsequently, if a particular  I-A haplo- 
type did not restrict a T  cell response,  we included mouse 
strains that also expressed I-E molecules to also include these 
possible restriction elements in the screen.  Out of the seven 
I-A +,I-E-  mouse strains  tested, which encompassed a spec- 
trum of standard I-A alleles, GAD ssp and Cox ssp were im- 
munogenic only in NOD mice (Table 1, columns A and B). 
We then  tested three strains  which,  in addition,  expressed 
the I-E alleles d, k, and u, respectively, but these I-E alleles 
did not restrict a T cell response to the peptides. Thus, out 
of 10 potential mouse class II restriction elements, only one, 
I-A  n~  restricted a T cell response to GAD ssp and Cox ssp. 
These data show that GAD ssp and Cox ssp can both bind 
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Materials  and Methods  Figure  1.  The mouse  GAD65 (27) and coxsackievirus  sequence  simihfity 
peptides (GAD ssp and Cox ssp) (4). Identical amino acid residues are 
Mice.  Nonobese diabetic (NOD mice) (Taconic Farms Inc., Ger-  boxed.  Numbers refer to the number of amino acid residues from the NH2 
mantown, NY) were maintained and bred under specific  pathogen-  terminus  of each protein. 
1980  Coxsackievirus  and Glutamate Decarboxylase  T Cell Cross-reactivity Table  1.  GAD65 and Cox P2-C Sequence Similarity Peptides (GAD ssp and Cox ssp) Induce Cross-reactive T  Cell Responses, 
but only in the Context of a Diabetes-associated Class 11 MHC 
Ia allele 
expressed 
Strain  I-A  I-E 
Lymph node T  cell proliferation  (cpm  x  10  z) 
A  B  C  D 
Immunized: Cox ssp  GAD ssp  Cox ssp  GAD ssp 
Recall: Cox ssp  GAD ssp  GAD ssp  Cox ssp 
Bm 12  6m12  -  1.9  2.0  2.1  2.9 
SJL  s  -  2.4  2.5  2.4  2.7 
B10.Q  q  -  2.3  2.4  2.5  2.8 
B10.A(4R)  k  -  2.3  2.2  1.9  1.8 
C57.BL/6  b  -  2.4  2.5  2.1  2.3 
B10.GD  d  -  2.7  1.9  2.4  1.9 
NOD  nod  -  65.3  67.8  32.5  46.6 
A/J  k  k  2.1  2.2  2.3  2.5 
B10.PL (73ns)  u  u  2.4  2.5  2.9  2.5 
BALB/c  d  d  3.6  2.3  2.8  2.8 
Lymph node T cell responses to GAD ssp and Cox ssp were tested in 10 strains of mice. Three to five male mice were immunized at 8 wk of 
age and tested 9 d later in two separate experiments. Background  for medium alone ranged from 1,500 to 2,400 cpm. Antigen-induced  proliferation 
that was >threefold  over background is indicated in bold. As a positive  control, PPD (5 #g/ml) induced proliferation  of about 38,000-64,000 cpm 
in all strains of mice. Data are expressed as average cpm  ￿  103. Cross-reactivity  was also observed at lower antigen concentrations (ranging from 
7 to 0.8 #M) in NOD mice. There  were no detectable spontaneous T cell responses to either peptides in the lymph node population of uninjected 
or B-Gal-immunized (Fig. 2) NOD mice. 
to I-A  n~  but owing to their sequence dissimilarities,  TCRs 
may discriminate between the two peptide-MHC complexes. 
However, we found that GAD ssp and Cox ssp are cross- 
reactively recognized: T cells primed by Cox ssp showed clear 
proliferative recall responses to GAD ssp and vice versa (Table 
1, columns C and D). The response recalled by the unrelated 
ssp was comparable in magnitude to the one recalled by the 
cognate peptide, suggesting that most T  cells in the lymph 
node population that recognized the nominal peptide also 
cross-reactively recognized the other ssp. Tolerance experi- 
ments also suggested that cross-reactivity was complete: toleri- 
zation of NOD mice to Cox ssp completely abrogated re- 
sponsiveness  to GAD ssp and vice versa (not shown).  The 
data demonstrate that, in spite of the sequence dissimilarities 
in the flanking regions, both peptides bind to I-A  n~  such 
that T  cell cross-reactivity occurs. 
It is possible that in the context of some of the H-2 haplo- 
types tested, the lack of immunogenicity by either sequence 
similarity peptide (Table 1) may not have resulted from a failure 
to bind to MHC, but rather from self-tolerance that had been 
established to the GAD65 sequence similarity determinant. 
In this case, complete cross-reactive presentation of both se- 
quence similarity determinants had to occur, because self- 
tolerance to the GAD65 sequence similarity determinant com- 
pletely abrogated responsiveness to Cox ssp. 
Since the motifs of peptide binding differ among the var- 
ious allelic products of the I-A and I-E locus, and the two 
ssp show considerable sequence variation (Fig. 1), we expected 
to observe four different restriction patterns in the panel of 
mouse strains tested: (a) neither ssp has affinity for a partic- 
1981 
ular allelic product and neither primes a T cell response; (b) 
one ssp, but not the other, constitutes a determinant; (c) both 
ssp  are  immunogenic,  but  their  spatial  orientation in  the 
MHC-peptide  complex is  unique  for  each  peptide,  thus 
preventing T  cell cross-reactivity; and (d) both ssp are im- 
munogenic and are cross-reactively recognized. It is surprising 
that of the 10 allelic class II products tested, we did not de- 
tect evidence for discordant binding (possibilities b and c). 
The pattern that we found may be biased due to conserved 
substitutions in the nonidentical residues between the two 
peptides. Most likely,  the number of different class II prod- 
ucts that we screened might not have been high enough to 
encompass all four binding patterns. 
Cross-reactive  priming  occurred  with  I-A  n~  but  not 
with I-A  d (Table 1), which differs in only two nonconserved 
amino acids from I-A  n~  in the relevant peptide binding do- 
main (18). Therefore, the two amino acid differences between 
the two alleles resulted in a unique phenotype. Even single 
amino acid substitutions on MHC molecules may have pro- 
found effects on peptide binding (19-21). Therefore, the sero- 
logically defined class II specificities of humans (e.g., DR3), 
which frequently encompass as many as 20 minor modifica- 
tions in primary amino acid  sequence, may display unique 
peptide binding properties depending on the specific expressed 
allele. Hence, only a certain subtype of a serologically defined 
specificity may be capable of restricting a cross-reactive T cell 
response and function as a "susceptibility allele"  for the in- 
duction of autoimmune disease. 
Whole GAD65 and Cox P2-C Induce Cross-reactive T  Cell 
Responses.  Whereas the above experiments demonstrate that 
Tian et al.  Brief  Definitive Report peptides that encompass the sequence similarity region can 
bind to I-A  "~  and can be cross-reactively  recognized by T 
cells,  these determinants might not actually be generated as 
dominant  determinants  after  the natural  processing  of the 
whole antigens. If GAD65 and Cox P2-C share a T cell de- 
terminant, immunization with one of these antigens should 
induce a T cell response that cross-reacts  with the other an- 
tigen,  and this response should be specific for the sequence 
similarity region.  Groups of NOD  mice were immunized 
with either the whole antigens (Cox P2-C, GAD65, and con- 
trol 3-galactosidase),  or with the peptides (Cox ssp, GAD 
ssp, and control HEL~I-ZS). Subsequently,  the recall response 
to all of these antigens  was  tested in each  mouse. 
The results  showed that, after natural processing of both 
GAD65 and Cox P2-C, the sequence similarity regions were 
generated as dominant  determinants:  Cox ssp recalled  a T 
cell response primed by whole Cox P2-C (Fig. 2 c) and vice 
versa (Fig. 2 d). Similarly,  GAD ssp recalled proliferation in 
the T  cell population  primed with whole GAD65  (Fig.  2 
e) and GAD ssp-primed cells proliferated  to whole GAD65 
and Cox P2-C  (Fig.  2 ~.  Mice immunized with GAD65, 
Cox P2-C, and the sequence similarity peptides showed no 
responses to control ~-galactosidase  and HELtt-25. Mice im- 
munized with the control antigens displayed no lymph node 
T  cell reactivity to GAD65  or Cox P2-C or their ssp (Fig. 
2, A  and B). 
With most protein antigens studied so far, processing of 
the native antigen results  in the presentation of only one, 
or a few peptide sequences  as dominant determinants (16). 
It is intriguing that among the vast number of potential pep- 
tide fragments on the two proteins (GAD65 is 585 and Cox 
P2-C is 329 amino acids),  both proteins were processed  to 
produce the sequence similarity region as a dominant deter- 
minant. Since the two proteins are otherwise unrelated,  the 
dominant display of the sequence similarity determinants  oc- 
curred  despite  the  existence  of unique  cleavage  sites  for 
lysosomal processing  and in the presence of a number of other 
potential determinants on the molecules that might have had 
higher affinity for MHC binding. 
Most importantly, cross-reactive recognition of the sequence 
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Figure  2.  T cell cross-reactivity 
between  GAD65  and  Cox  P2-C. 
NOD  mice  were  immunized  at 
3 wk  of age  with  control  B-Gal 
(a), control HELlI-~  peptide (b), 
whole Cox P2-C (c),  Cox ssp (d), 
whole GAD65 (e), or GAD ssp ~. 
9  d  after  immunization,  lymph 
nodes  were  assayed  for  T  cell  re- 
sponses to all six antigens. Three to 
four mice from each experimental 
and  control  group  were  assayed 
simultaneously in two separate ex- 
periments. The data from both ex- 
periments were pooled and the data 
are expressed  as stimulation index 
(SI) _+ SEM. (Shaded bats) Antigens 
that triggered significant T cell re- 
sponses (SI I>3.0). The background 
in all experiments was ~500-2,000 
cpm. 
1982  Coxsackievirus  and Glutamate Decarboxylase  T  Cell Cross-reactivity similarity regions  also occurred after natural  processing of 
the whole Cox P2-C and GAD65. After priming with whole 
Cox P2-C protein, GAD65 and GAD ssp recalled a response 
of comparable magnitude to that of recall with the Cox ssp 
itself (Fig.  2 c). Also, in the T cell population primed with 
whole GAD65, responses to GAD ssp, Cox ssp, and whole 
Cox P2-C protein were recalled and were of comparable mag- 
nitude (Fig.  2 e). Apparently, the determinants generated by 
proteases during  processing of the whole antigens yielded 
determinants  that behaved in a manner identical to that of 
the ssp we synthesized (Fig. 1). Furthermore, these naturally 
generated determinants  were displayed on I-A  n~  molecules 
indistinguishably,  with regard  to  T  cell recognition. 
In conclusion,  we have demonstrated  that  cross-reactive 
T  cell recognition of the Cox P2-C/GAD65  sequence sim- 
ilarity occurs in the context of only I out of 10 MHC alleles 
tested. The observed constraints on T cell cross-reactivity im- 
posed by the processing and presentation of antigen may ex- 
plain why common pathogens do not induce widespread T 
cell-mediated autoimmune diseases despite the frequent se- 
quence similarities present in common pathogens. T cell cross- 
reactivity may only be inducible in a small fraction of a popu- 
lation that  possesses specific  MHC susceptibility alleles.  It 
is striking that dominant display and cross-reactive recogni- 
tion of the sequence similarity regions within the two diabetes- 
associated antigens occurred only in the context of a diabeto- 
genic MHC allele. This suggests that the cross-reactivity we 
observed may not have been a random event but rather a re- 
sult of molecular mimicry, i.e., the evolutionary adaptation 
of a dominant coxsackievirus determinant to mimic a domi- 
nant GAD65 determinant in order to evade a host immune 
response. Coxsackievirus has a broad host range,  and mim- 
icry may have evolved to MHC  alleles  that  share peptide 
binding motifs among these species. This adaptation may pro- 
vide a selective advantage to the virus in hosts whose MHC 
alleles cross-reactively present the two determinants but fail 
to respond to the viral determinant  due to self-tolerance to 
the GAD65 determinant.  In contrast,  this adaptation  may 
result in autoimmunity in hosts that have not established self- 
tolerance to the GAD65 determinant.  If we exclude the di- 
abetogenic allele  from consideration  (because the observed 
cross-reactivity may be nonrandom), the frequency of MHC 
alleles capable of restricting a cross-reactive response may be 
far less than i  in 10 within a broader spectrum of allelic re- 
striction  elements,  as occurs in the human  population. 
Whereas coxsackievirus infection is not suspect in the patho- 
genesis of murine IDDM, it has been epidemiologicaUy as- 
sociated with human IDDM (8-10). The routine and human 
class II susceptibility alleles for IDDM share  structural fea- 
tures (18, 22, 23). In addition, autoreactive T cells from NOD 
mice and IDDM patients appear to recognize similar deter- 
minants in GAD65 (11, 24, 25), and HSP (26).  Therefore, 
the cross-reactive presentation of the Cox P2-C and GAD65 
that we have observed in NOD mice may also occur with 
the context of human susceptibility alleles. Consistent with 
this hypothesis, peptides containing  the GAD65 region of 
sequence similarity with coxsackievirus bind well to human 
DQwS,  a  MHC  haplotype  that  confers  susceptibility  to 
IDDM (Wicker, L., personal communication)  and are the 
major determinant  recognized by PBMC from individuals 
at high risk for IDDM (24). Thus, the T cell cross-reactivity 
that  we describe here  in  a murine  model  system may,  in 
humans,  contribute to the initiation  or amplification  of B 
cell autoimmunity and the association of IDDM with cer- 
tain  HLA alleles. 
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